
Abbott Laboratories ABT
$ 102.3
0.0%
Annual report 2025
added 02-20-2026
Abbott Laboratories Total Liabilities 2011-2026 | ABT
Annual Total Liabilities Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 36.6 B | 36.5 B | 45.2 B | 31.9 B | 19.9 B | 19.6 B | 17.7 B | 40.4 B | 35.8 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 45.2 B | 17.7 B | 31.5 B |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Bruker Corporation
BRKR
|
3.99 B | $ 36.74 | - | $ 5.47 K | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 9.38 | - | $ 266 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.59 | - | $ 36.7 M | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.07 | - | $ 1.63 B | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 9.7 | - | $ 347 M | ||
|
EDAP TMS S.A.
EDAP
|
34.6 M | $ 3.45 | 1.77 % | $ 129 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 81.19 | - | $ 47.5 B | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 18.6 | - | $ 122 M | ||
|
Globus Medical
GMED
|
730 M | $ 88.6 | - | $ 12 B | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.9 | - | $ 1.15 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 9.31 | - | $ 717 M | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 54.14 | - | $ 1.59 B | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.0 | - | $ 16.9 M | ||
|
Integer Holdings Corporation
ITGR
|
1.66 B | $ 85.63 | - | $ 2.97 B | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.94 | - | $ 374 M | ||
|
LENSAR
LNSR
|
83.7 M | $ 5.89 | -2.81 % | $ 70.4 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
Medtronic PLC
MDT
|
43.4 B | $ 86.28 | - | $ 111 B | ||
|
Align Technology
ALGN
|
2.36 B | $ 171.87 | - | $ 12.9 B | ||
|
Myomo
MYO
|
27.2 M | $ 0.7 | - | $ 29.3 M | ||
|
AxoGen
AXGN
|
92.8 M | $ 32.64 | - | $ 1.5 B | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Orthofix Medical
OFIX
|
401 M | $ 11.77 | - | $ 466 M | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Penumbra
PEN
|
399 M | $ 329.87 | - | $ 12.8 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Insulet Corporation
PODD
|
1.68 B | $ 203.5 | - | $ 14.3 B | ||
|
Sintx Technologies
SINT
|
6.58 M | $ 2.53 | 0.4 % | $ 7.02 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 4.13 | -0.24 % | $ 874 M | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Smith & Nephew plc
SNN
|
5.17 B | $ 32.63 | - | $ 23.8 B | ||
|
Stryker Corporation
SYK
|
25.4 B | $ 332.3 | - | $ 127 B | ||
|
Tactile Systems Technology
TCMD
|
55 M | $ 24.57 | - | $ 562 M | ||
|
TELA Bio
TELA
|
75.1 M | $ 0.63 | 5.47 % | $ 29.6 M | ||
|
TransMedics Group
TMDX
|
595 M | $ 104.8 | - | $ 3.56 B | ||
|
Tandem Diabetes Care
TNDM
|
726 M | $ 19.17 | - | $ 1.3 B | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M |